Developmental Therapeutics

The Developmental Therapeutics Program combines expertise in protein structure and modeling, cancer cell signaling, developmental therapeutics and clinical trial, to address the realization that modern drug discovery and development requires a multidisciplinary and interactive process. Co-led by Gregory Adams, PhD, and Erica Golemis, PhD, the major focus of the program is to develop and refine new cancer treatments, integrating the efforts of basic and clinical researchers in a highly collegial environment. Below is the list of researchers working on each project.

Program Leaders

CCSG Members
from Temple University

Biomolecular Structure and Function

Cancer Signaling

Clinical Therapeutics

[3/28/2014]